1.Adamkin DH.Metabolic screening and postnatal glucose homeostasis in the newborn.Pediatric clinics of North America，2015，62（2）：385-409.

2.Berry SA.Newborn screening.Clinics in perinatology，2015，42（2）：441-453，x.

3.Burlina AP，Sims KB，Politei JM，et al. Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain：the report of an expert panel.BMC neurology，2011，11：61.

4.Carrillo-Carrasco N，Chandler RJ，Venditti CP.Combined methylmalonic acidemia and homocystinuria，cblC type.I.Clinical presentations，diagnosis and management.Journal of inherited metabolic disease，2012，35（1）：91-102.

5.Chace DH，Spitzer AR.Altered metabolism and newborn screening using tandem mass spectrometry：lessons learned from the bench to bedside.Current pharmaceutical biotechnology，2011，12（7）：965-975.

6.Champion MP.An approach to the diagnosis of inherited metabolic disease.Archives of disease in childhood Education and practice edition，2010，95（2）：40-46.

7.Choi R，Woo HI，Choe BH，et al. Application of whole exome sequencing to a rare inherited metabolic disease with neurological and gastrointestinal manifestations：a congenital disorder of glycosylation mimicking glycogen storage disease.Clinica chimica acta； international journal of clinical chemistry，2015，444：50-53.

8.Concolino P，Mello E，Zuppi C，et al. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency：an update of new CYP21A2 mutations.Clinical chemistry and laboratory medicine，2010，48（8）：1057-1062.

9.Cook P，Walker V.Investigation of the child with an acute metabolic disorder.Journal of clinical pathology，2011，64（3）：181-191.

10.De Luca C，Raskovic D，Pacifico V，et al. The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances.International journal of environmental research and public health，2011，8（7）：2770-2797.

11.Dos Santos OC，Schultz R.The infantile-onset form of Pompe disease：an autopsy diagnosis.Autopsy &case reports，2015，5（4）：45-51.

12.Elmonem MA，Mahmoud IG，Mehaney DA，et al.Lysosomal Storage Disorders in Egyptian Children.Indian journal of pediatrics，2016.

13.Ezgu F.Inborn Errors of Metabolism.Advances in clinical chemistry，2016，73：195-250.

14.Fernandez-Lainez C，Ibarra-Gonzalez I，Belmont-Martinez L，et al. Tyrosinemia type I：clinical and biochemical analysis of patients in Mexico.Annals of hepatology，2014，13（2）：265-272.

15.Filocamo M，Morrone A.Lysosomal storage disorders：molecular basis and laboratory testing.Human genomics，2011，5（3）：156-169.

16.Fuller M，Szer J，Stark S，et al. Rapid，single-phase extraction of glucosylsphingosine from plasma：A universal screening and monitoring tool.Clinica chimica acta； international journal of clinical chemistry，2015，450：6-10.

17.Gasson T，Klein K.Porphyria：Pathophysiology，diagnosis，and treatment.The Nurse practitioner，2015，40（8）：1-6.

18.Gattineni J.Inherited disorders of calcium and phosphate metabolism.Current opinion in pediatrics，2014，26（2）：215-222.

19.Giordano C，Iommarini L，Giordano L，et al.Efficient mitochondrial biogenesis drives incomplete penetrance in Leber’s hereditary optic neuropathy.Brain：a journal of neurology，2014，137（Pt 2）：335-353.

20.Gotoh K，Nakajima Y，Tajima G，et al. Assay for methylmalonyl coenzyme A mutase activity based on determination of succinyl coenzyme A by ultrahighperformance liquid chromatography tandem mass spectrometry.Analytical and bioanalytical chemistry，2015，407（18）：5281-5286.

21.Han L，Han F，Ye J，et al. Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry.Journal of clinical laboratory analysis，2015，29（2）：162-168.

22.Henley WE，Anderson LJ，Wyatt KM，et al.The NCS-LSD cohort study：a description of the methods and analyses used to assess the longterm effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disorders.Journal of inherited metabolic disease，2014，37（6）：939-944.

23.Hernandez MA，Schulz R，Chaplin T，et al. The diagnosis of inherited metabolic diseases by microarray gene expression profiling.Orphanet journal of rare diseases，2010，5：34.

24.Ibrahim M，Parmar HA，Hoefling N，et al. Inborn errors of metabolism：combining clinical and radiologic clues to solve the mystery.AJR American journal of roentgenology，2014，203（3）：W315-327.

25.Janeckova H，Hron K，Wojtowicz P，et al. Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.Journal of chromatography A，2012，1226：11-17.

26.Janeckova H，Kalivodova A，Najdekr L，et al.Untargeted metabolomic analysis of urine samples in the diagnosis of some inherited metabolic disorders.Biomedical papers of the Medical Faculty of the University Palacky，Olomouc，Czechoslovakia，2015，159（4）：582-585.

27.Jones PM，Bennett MJ.Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry.Methods in molecular biology，2010，603：423-431.

28.Kolker S，Christensen E，Leonard JV，et al.Diagnosis and management of glutaric aciduria type I—revised recommendations.Journal of inherited metabolic disease，2011，34（3）：677-694.

29.Lampe C，Bellettato CM，Karabul N，et al. Mucopolysaccharidoses and other lysosomal storage diseases.Rheumatic diseases clinics of North America，2013，39（2）：431-455.

30.Lawrence R，Brown JR，Al-Mafraji K，et al. Diseasespecific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses.Nature chemical biology，2012，8（2）：197-204.

31.Liu XM，Li R，Chen SZ，et al. Screening of Inherited Metabolic Disorders in Infants with Infantile Spasms.Cell biochemistry and biophysics，2015，72（1）：61-65.

32.Lund AM，Hougaard DM，Simonsen H，et al.Biochemical screening of 504，049 newborns in Denmark，the Faroe Islands and Greenland—experience and development of a routine program for expanded newborn screening.Molecular genetics and metabolism，2012，107（3）：281-293.

33.Martins E，Cardoso ML，Rodrigues E，et al.Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency：the clinical relevance of an early diagnosis and report of four new cases.Journal of inherited metabolic disease，2011，34（3）：835-842.

34.Metz TF，Mechtler TP，Orsini JJ，et al. Simplified newborn screening protocol for lysosomal storage disorders.Clinical chemistry，2011，57（9）：1286-1294.

35.Meyers DE，Basha HI，Koenig MK.Mitochondrial cardiomyopathy：pathophysiology，diagnosis，and management.Texas Heart Institute journal，2013，40（4）：385-394.

36.Mochel F.Outline of metabolic diseases in adult neurology.Revue neurologique，2015，171（6-7）：531-538.

37.Narayanan MP，Kannan V，Vinayan KP，et al.Diagnosis of major organic acidurias in children：two years experience at a tertiary care centre.Indian journal of clinical biochemistry：IJCB，2011，26（4）：347-353.

38.Patel J，Mercimek-Mahmutoglu S.Epileptic Encephalopathy in Childhood：A Stepwise Approach for Identification of Underlying Genetic Causes.Indian journal of pediatrics，2016.

39.Peters V，Bonham JR，Hoffmann GF，et al.Qualitative urinary organic acid analysis：10 years of quality assurance.Journal of inherited metabolic disease，2016.

40.Scala I，Parenti G，Andria G.Universal screening for inherited metabolic diseases in the neonate（and the fetus）.The journal of maternal-fetal & neonatal medicine：the official journal of the European Association of Perinatal Medicine，the Federation of Asia and Oceania Perinatal Societies，the International Society of Perinatal Obstet，2012，25（Suppl 5）：4-6.

41.Selim LA，Hassan SA，Salem F，et al. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children：a 5 year report.Clinical biochemistry，2014，47（9）：823-828.

42.Spada M，Porta F，Vercelli L，et al. Screening for later-onset Pompe’s disease in patients with paucisymptomatic hyperCKemia.Molecular genetics and metabolism，2013，109（2）：171-173.

43.Szymanska K，Lugowska A，Laure-Kamionowska M，et al. Diagnostic difficulties in Krabbe disease：a report of two cases and review of literature.Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre，Polish Academy of Sciences，2012，50（4）：346-356.

44.Tasic V，Gucev Z.Nephrolithiasis and Nephrocalcinosis in Children-Metabolic and Genetic Factors.Pediatric endocrinology reviews：PER，2015，13（1）：468-476.

45.Terek D，Koroglu O，Yalaz M，et al. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.Neuropediatrics，2013，44（4）：208-212.

46.Vogel BH，Bradley SE，Adams DJ，et al. Newborn screening for X-linked adrenoleukodystrophy in New York State：diagnostic protocol，surveillance protocol and treatment guidelines.Molecular genetics and metabolism，2015，114（4）：599-603.

47.Wertheim-Tysarowska K，Gos M，Sykut-Cegielska J，et al. Genetic analysis in inherited metabolic disorders—from diagnosis to treatment.Own experience，current state of knowledge and perspectives.Developmental period medicine，2015，19（4）：413-431.

48.Yang Y，Wu J，Liu H，et al. Two homozygous nonsense mutations of GNPTAB gene in two Chinese families with mucolipidosis II alpha/beta using targeted next-generation sequencing.Genomics，2013，102（3）：169-173.

49.Yohe S，Hauge A，Bunjer K，et al. Clinical validation of targeted next-generation sequencing for inherited disorders.Archives of pathology &laboratory medicine，2015，139（2）：204-210.

50.Yoon HR.Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry.Annals of pediatric endocrinology & metabolism，2015，20（3）：119-124.